Skip to main content
OpenTrials
Completed

NCT Number: NCT02932163

Predictors of Chronic Non-specific Low Back Pain

Chronic non-specific low back pain (CNSLBP) has been defined as a persistent pain in the lower back for at least three months with no known causes. The CNSLBP prevalence is estimated of 90% among all types of the LBP. The LBP imposes high direct and indirect costs on the patients and the society. Whereas a specific pathology has not been identified for CNSLBP, mechanical factors (e.g. changes in muscle length, strength, or endurance) may contribute to the pain and disability.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with chronic non-specific LBP,
  • LBP duration ≥ 6 months.

Exclusion criteria

  • spinal osteoarthritis,
  • spondylolisthesis,
  • history of vertebral fractures.

Treatment and study plan

Primary outcomes

  1. Change of Pain intensity

    Time frame: Baseline

    Visual Analogue Scale

  2. Change of Disability

    Time frame: Baseline

    Oswestry disability index

Sponsors and collaborators

Lead sponsor

Fondazione Don Carlo Gnocchi ETS

Other

Registry information

Official study title

Relationships Between Muscular Impairments, Pain, and Disability in Patients With Chronic Non-specific Low Back Pain: a Cross Sectional Study

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Oct 13, 2016
Registry last updated
Oct 13, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.